Core Equivalence

Core Equivalence - Header

info@coreequivalence.com

Time at current Location	London	Shanghai	Lagos	New York	Sao Paulo	Sydney

A technologically savvy deal maker is our best user

Business leads at the pre-origination phase of deal making is our focus

CoreEquivalence data input requirement ensure security and confidentiality

CoreEquivalence technological depth, increasingly, sifting out time wasters

CoreEquivalence, finding the best home for your asset at the best price

A negative cash flow business posted on CoreEquivalence will still find interest

Increasing numbers of users, the better your results on CoreEquivalence

CoreEquivalence creating a better world in the deal making space.

A technologically savvy deal maker is our best user

Business leads at the pre-origination phase of deal making is our focus

CoreEquivalence data input requirement ensure security and confidentiality

CoreEquivalence technological depth, increasingly, sifting out time wasters

A negative cash flow business posted on CoreEquivalence will still find interest

Increasing numbers of users, the better your results on CoreEquivalence

A technologically savvy deal maker is our best user

Science, Biotech & Pharmaceuticals Development

Apply Now ››

Continent / Region : /

Country : New Caledonia

Location :

Industry : Science, Biotech & Pharmaceuticals

Cost or Price of Project and Infrastructure : £ 90,000,000.00

Revenues Life of Project and Infrastructure :

Finance Type : Any Finance Type

Transaction Type : Any transaction type

Business Type : Project and Infrastructure

Sell Side or Buy Side :

Net Income : £

Project IRR on the Cashflows :

Our investors are interested Science, Biotech & Pharmaceuticals Investments, Business developments and Implementations, and applicable Science, Biotech & Pharmaceuticals human resources and service experts in the New Caledonia. Will like to support investors and clients in these initiatives and ventures. Requirements and expertise required are not limited to the following: * promoting the investments and development of Science, Biotech & Pharmaceuticals * maintenance or improvement of health solution via Science, Biotech & Pharmaceuticals * Science, Biotech & Pharmaceuticals development policies in places, communities and countries * Analysis and development of Science, Biotech & Pharmaceuticals systems * Science, Biotech & Pharmaceuticals Equipments and facilities * Science, Biotech & Pharmaceuticals Planning * Well maintained Science, Biotech & Pharmaceuticals facilities and logistics to deliver quality medicines and technologies. * help participating experts and companies, in the legal process and framework, to design appropriate and effective marketing strategies to overcome local and international barriers. * Outsourcing * Start up * Balance growth and environmental concerns. PLEASE, submit interest that will assist in matching buyers and sellers. Note: This proposition does not bind the buyer or seller to any offer, financial or otherwise.

Cost or price of Project and Infrastructure

£ 90000000

Net Income

£ 0.00

Reference :

Tax Rate : £

Equity IRR on the Cashflows :

Minimum DSCR :

Average DSCR :

Start Date :

End Date :

Security Clearance :

Any Current Debt :

Preferred / Required Transaction Timeframe : 90 days

Post Duration :

Life of Project and Infrastructure :

EBIT :

Inflation Rate :

Reason for sale :

Signed Letter of Intent :

Signed NDA Applicable :

Signed Financial Status Report Applicable :

Business Language :

Net Profit : Aleast 10% to 15% of revenue

Reference Number : CE-107749-UK-ALL-SBP-107749

CoreEquivalence Important Disclosures

Location on Map

Apply Now ››